Status | Study |
NOT_YET_RECRUITING |
Study Name: Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age Condition: Hyperkalemia Date: 2023-01-19 Interventions: Patiromer will be given once daily; In Cohort 3, depending on the dose and the study participant's age, the total daily dose might be split |
RECRUITING |
Study Name: Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects Condition: Hyperkalemia Date: 2021-11-15 Interventions: Participants initiate patiromer at an oral dose of 1 packet/day (8.4g/day as powder for suspension).The dose is adjusted ate the fo |
Not yet recruiting |
Study Name: ZS Ph2/3 Dose-response Study in Japan Condition: Hyperkalemia Date: 2017-04-05 Interventions: Drug: Sodium Zirconium Cyclosilicate (ZS) 5g |
Not yet recruiting |
Study Name: Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia Condition: Hyperkalemia Date: 2017-03-16 Interventions: Drug: Patiromer 4.2 g/day, 8.4 |
Recruiting |
Study Name: A Study Evaluating the Onset-of-Action, Safety, and Efficacy of RDX227675 for the Treatment of Hyperkalemia Condition: Hyperkalemia Date: 2017-01-10 Interventions: Drug: RDX227675 Drug: Placebo |
Recruiting |
Study Name: Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE) Condition: Kidney Failure, Chronic Date: 2016-08-25 Interventions: Drug: Patiromer 25.2 g Single dose of Patiromer 25.2 g |
Recruiting |
Study Name: A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia Condition: Hyperkalemia Date: 2016-07-22 Interventions: Drug: Sodium Zirconium Cyclosilicate (ZS) 10g |
Completed |
Study Name: Patiromer With or Without Food for the Treatment of Hyperkalemia Condition: Hyperkalemia Date: 2016-02-25 Interventions: Drug: patiromer 8.4 g/day starting dose, administered orally |
Completed |
Study Name: How Much Reliable iv Calcium for the Treatment of Hyperkalemia? Condition: Acute Renal Failure Chronic Renal Failure Date: 2016-01-17 Interventions: Device: Electrocardiogram (ECG) ECG and vital parameters were obtained before and after recommended stan |
Completed |
Study Name: POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study Condition: Hyperkalemia Date: 2015-11-17 Interventions: Device: Cardiac rhythm remote monitoring system Non-invasive wearable remote cardiac rhythm monitoring s |